![UMN logo](/assets/logo-14ca9c5bc764343ea0b1ec3edef3d39b15c438f8eb603b1a5fbf826128a74246.png)
StudyFinder
MT2022-49: Early identification of cognitive side-effects of immunotherapy
![](/assets/flag-998f631fa7bef54098575ae881e66e71315bfae4a5d1ffb34ab8f527fcff0600.jpg)
Recruiting
This study is testing different ways to look for neurologic side effects in patients who get CAR-T therapy for their cancer.
Male or Female
18 years and over
Inclusion Criteria:
• planning to have inpatient CAR-T therapy for primary cancer
• fluent in English (written or spoken)
Exclusion Criteria:
• presence of speech or hearing problem
• diagnosis of cognitive impairment
Cancer
Clinics and Surgery Center (CSC), CAR-T, Chimeric Antigen Receptor T-Cell Therapy
Veronika Bachanova - bach0173@umn.edu
Veronika Bachanova, MD
STUDY00019811
See this study on ClinicalTrials.gov